We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

'Copycats' Can't Push Zetia Antitrust MDL To NY, Panel Told

Law360, Chicago (May 31, 2018, 7:58 PM EDT) -- The Judicial Panel on Multidistrict Litigation on Thursday questioned the motives of attorneys requesting the centralization of suits claiming Merck & Co. Inc. conspired with a generics maker to stifle competition for its drug Zetia, with one panel judge asking whether the real fight was over the appointment of lead counsel.

At the panel’s hearing in Chicago, judges pressed an attorney for the Philadelphia Federation of Teachers Health and Welfare Fund to respond to allegations from other plaintiffs that the group pushing for an MDL in...
To view the full article, register now.



Case Information

Case Title

IN RE: Zetia (Ezetimibe) Antitrust Litigation

Case Number



Judicial Panel on Multidistrict Litigation

Nature of Suit


Rebecca Beach Smith

Date Filed

February 28, 2018

Law Firms


Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.